Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha)

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100–10. doi:10.1093/carcin/bgp263
   PubMed Web of Science ®Google Scholar
• Cagan R, Meyer P. Rethinking cancer: current challenges and opportunities in cancer research. The Company of Biologists Ltd, 2017.
   Google Scholar
• Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S, Nair MG. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets. 2006;10(1):87–118. doi:10.1517/14728222.10.1.87
   PubMed Web of Science ®Google Scholar
• Metri K, Bhargav H, Chowdhury P, Koka PS. Ayurveda for chemo-radiotherapy induced side effects in cancer patients. J Stem Cells. 2013;8(2):115–29.
   PubMedGoogle Scholar
• Baliga MS, Meera S, Vaishnav LK, Rao S, Palatty PL. Rasayana drugs from the Ayurvedic system of medicine as possible radioprotective agents in cancer treatment. Integr Cancer Ther. 2013;12(6):455–63. doi:10.1177/1534735413490233
   PubMed Web of Science ®Google Scholar
• Greenwell M, Rahman P. Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res. 2015;6(10):4103–12. doi:10.13040/IJPSR.0975-8232.6(10).4103-12
   PubMed Web of Science ®Google Scholar
• Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT. Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed. 2017;7(12):1129–50. doi:10.1016/j.apjtb.2017.10.016
   Web of Science ®Google Scholar
• Roy RV, Suman S, Das TP, Luevano JE, Damodaran C. Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells. J Nat Prod. 2013;76(10):1909–15. doi:10.1021/np400441f
   PubMed Web of Science ®Google Scholar
• Hsu J-M, Chang P-H, Cheng T-S, Kuo Y-L, Wu A-H, et al. Identification of Withaferin A as a potential candidate for anti-cancer therapy in non-small cell lung cancer. Cancers. 2019;11:1003. doi:10.3390/cancers11071003
   PubMed Web of Science ®Google Scholar
• Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer. 2011;129(11):2744–55. doi:10.1002/ijc.25938
   PubMed Web of Science ®Google Scholar
• Grogan PT, Sleder KD, Samadi AK, Zhang H, Timmermann BN, Cohen MS. Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways. Invest New Drugs. 2013;31(3):545–57. doi:10.1007/s10637-012-9888-5
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1093–105. doi:10.1016/j.pnpbp.2007.09.011
   PubMed Web of Science ®Google Scholar
• Tiwari R, Chakrabort S, Saminathan M, Dhama K, Singh SV. Ashwagandha (Withania somnifera): role in safeguarding health, immunomodulatory effects, combating infections and therapeutic applications: a review. J Biol Sci. 2014;14(2):77–94. doi:10.3923/jbs.2014.77.94
   Google Scholar
• Choudhary D, Bhattacharyya S, Bose S. Efficacy and safety of Ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions. J Diet Suppl. 2017;14(6):599–612. doi:10.1080/19390211.2017.1284970
   PubMedGoogle Scholar
• Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera, the Indian ginseng. Cell Mol Life Sci. 2015;72(23):4445–60. doi:10.1007/s00018-015-2012-1
   PubMed Web of Science ®Google Scholar
• Gorelick J, Rosenberg R, Smotrich A, Hanuš L, Bernstein N. Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry. 2015;116:283–9. doi:10.1016/j.phytochem.2015.02.029
   PubMed Web of Science ®Google Scholar
• Gupta A, Singh S. Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats. Pharm Biol. 2014;52(3):308–20. doi:10.3109/13880209.2013.835325
   PubMed Web of Science ®Google Scholar
• Mohanty IR, Arya DS, Gupta SK. Withania somnifera provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis. Clin Nutr. 2008;27(4):635–42. doi:10.1016/j.clnu.2008.05.006
   PubMed Web of Science ®Google Scholar
• RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. J Ethnopharmacol. 2009;125(3):369–73. doi:10.1016/j.jep.2009.08.003
   PubMed Web of Science ®Google Scholar
• Bhatnagar M, Goel I, Roy T, Shukla SD, Khurana S. Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice. PloS One. 2017;12(5):e0177254doi:10.1371/journal.pone.0177254
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, Dayakar A, Veronica J, Sundar S, Maurya R. An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. Parasitol Int. 2013;62(3):253–61. doi:10.1016/j.parint.2013.01.007
   PubMed Web of Science ®Google Scholar
• Sachdeva H, Sehgal R, Kaur S. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitol Res. 2013;112(6):2269–80. doi:10.1007/s00436-013-3387-2
   PubMed Web of Science ®Google Scholar
• Reuland DJ, Khademi S, Castle CJ, Irwin DC, McCord JM, Miller BF, Hamilton KL. Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic Biol Med. 2013;56:102–11. doi:10.1016/j.freeradbiomed.2012.11.016
   PubMed Web of Science ®Google Scholar
• Kurup P. The antibacterial principle of Withania somnifera. I. Isoation and antibacterial activity. Antibio Chemotherapy (Northfield, Ill). 1958;8:511–5.
   PubMedGoogle Scholar
• Devi PU, Sharada A, Solomon F, Kamath MS. In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol. 1992;30(3):169–72.
   PubMedGoogle Scholar
• Singh N, Singh SP, Nath R, Singh DR, Gupta ML, Kohli RP, Bhargava KP. Prevention of urethane-induced lung adenomas by Withania somnifera (L.) Dunal in albino mice. Int J Crude Drug Res. 1986;24(2):90–100. doi:10.3109/13880208609083312
   Google Scholar
• Senthilnathan P, Padmavathi R, Banu SM, Sakthisekaran D. Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer. Chem Biol Interact. 2006;159(3):180–5. doi:10.1016/j.cbi.2005.11.003
   PubMed Web of Science ®Google Scholar
• Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D. Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer. Cancer Sci. 2006;97(7):658–64. doi:10.1111/j.1349-7006.2006.00224.x
   PubMed Web of Science ®Google Scholar
• Oh JH, Kwon TK. Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells. Int Immunopharmacol. 2009;9(5):614–9. doi:10.1016/j.intimp.2009.02.002
   PubMed Web of Science ®Google Scholar
• Kyakulaga AH, Aqil F, Munagala R, Gupta RC. Withaferin A inhibits epithelial to mesenchymal transition in non-small cell lung cancer cells. Sci Rep. 2018;8(1):15737doi:10.1038/s41598-018-34018-1
   PubMed Web of Science ®Google Scholar
• Cai Y, Sheng Z-Y, Chen Y, Bai C. Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer. Asian Pac J Cancer Prev: APJCP. 2014;15(4):1711–4. doi:10.7314/APJCP.2014.15.4.1711
   PubMedGoogle Scholar
• Arpino G, Milano M, De Placido S. Features of aggressive breast cancer. Breast. 2015;24(5):594–600. doi:10.1016/j.breast.2015.06.001
   PubMed Web of Science ®Google Scholar
• Stan SD, Zeng Y, Singh SV. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer. 2008;60(sup1):51–60. doi:10.1080/01635580802381477
   PubMed Web of Science ®Google Scholar
• Stan SD, Hahm E-R, Warin R, Singh SV. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008;68(18):7661–9. doi:10.1158/0008-5472.CAN-08-1510
   PubMed Web of Science ®Google Scholar
• Hahm E-R, Singh SV. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Cancer Lett. 2013;334(1):101–8. doi:10.1016/j.canlet.2012.08.026
   PubMed Web of Science ®Google Scholar
• Hahm E-R, Moura MB, Kelley EE, Van Houten B, Shiva S, Singh SV. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PloS One. 2011;6(8):e23354doi:10.1371/journal.pone.0023354
   PubMed Web of Science ®Google Scholar
• Bargagna-Mohan P, Hamza A, Kim Y-e, Khuan Abby Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan C-G, et al. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem Biol. 2007;14(6):623–34. doi:10.1016/j.chembiol.2007.04.010
   PubMedGoogle Scholar
• Yang Z, Garcia A, Xu S, Powell DR, Vertino PM, Singh S, Marcus AI. Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One. 2013;8(9):e75069. doi:10.1371/journal.pone.0075069
   PubMed Web of Science ®Google Scholar
• Khazal KF, Hill DL. Withania somnifera extract reduces the invasiveness of MDA-MB-231 breast cancer and inhibits cytokines associated with metastasis. J Cancer Metastasis Treat. 2015;1(2):94. doi:10.4103/2394-4722.157601
   PubMedGoogle Scholar
• Khazal KF, Samuel T, Hill DL, Grubbs CJ. Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas. Anticancer Res. 2013;33(4):1519–23.
   PubMed Web of Science ®Google Scholar
• Hahm ER, Lee J, Huang Y, Singh SV. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Mol Carcinog. 2011;50(8):614–24. doi:10.1002/mc.20760
   PubMed Web of Science ®Google Scholar
• Lee J, Hahm ER, Marcus AI, Singh SV. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Mol Carcinog. 2015;54(6):417–29. doi:10.1002/mc.22110
   PubMed Web of Science ®Google Scholar
• Lee J, Hahm E-R, Singh SV. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis. 2010;31(11):1991–8. doi:10.1093/carcin/bgq175
   PubMed Web of Science ®Google Scholar
• Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, Dewitt DL, Holmes D, Sung B, Aggarwal BB, Tsay H-S, Nair MG. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res. 2009;23(7):987–92. doi:10.1002/ptr.2736
   PubMed Web of Science ®Google Scholar
• Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat. 2012;136(1):45–56. doi:10.1007/s10549-012-2239-6
   PubMed Web of Science ®Google Scholar
• Kim S-H, Singh SV. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells. Cancer Prev Res (Phila)). 2014;7(7):738–47. doi:10.1158/1940-6207.CAPR-13-0445
   PubMed Web of Science ®Google Scholar
• Nagalingam A, Kuppusamy P, Singh SV, Sharma D, Saxena NK. Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. Cancer Res. 2014;74(9):2617–29. doi:10.1158/0008-5472.CAN-13-2081
   PubMed Web of Science ®Google Scholar
• Szarc Vel Szic K, Declerck K, Crans RAJ, Diddens J, Scherf DB, Gerhäuser C, Vanden Berghe W. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. Oncotarget. 2017;8(25):40434–53. doi:10.18632/oncotarget.17107
   PubMedGoogle Scholar
• Shah N, Kataria H, Kaul SC, Ishii T, Kaur G, Wadhwa R. Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci. 2009;100(9):1740–7. doi:10.1111/j.1349-7006.2009.01236.x
   PubMed Web of Science ®Google Scholar
• Grogan P, Samadi A, Cohen M. A novel cytotoxic agent induces apoptosis in malignant gliomas in vitro. J Surg Res. 2010;158(2):341–2. doi:10.1016/j.jss.2009.11.468
   Google Scholar
• Gao R, Shah N, Lee J-S, Katiyar SP, Li L, Oh E, Sundar D, Yun C-O, Wadhwa R, Kaul SC. Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K. Mol Cancer Ther. 2014;13(12):2930–40. doi:10.1158/1535-7163.MCT-14-0324
   PubMed Web of Science ®Google Scholar
• Kataria H, Wadhwa R, Kaul SC, Kaur G. Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas. PLoS One. 2013;8(1):e55316. doi:10.1371/journal.pone.0055316
   PubMed Web of Science ®Google Scholar
• Kataria H, Kumar S, Chaudhary H, Kaur G. Withania somnifera suppresses tumor growth of intracranial allograft of glioma cells. Mol Neurobiol. 2016;53(6):4143–58. doi:10.1007/s12035-015-9320-1
   PubMed Web of Science ®Google Scholar
• Sun GY, Li R, Cui J, Hannink M, Gu Z, Fritsche KL, Lubahn DB, Simonyi A. Withania somnifera and its withanolides attenuate oxidative and inflammatory responses and up-regulate antioxidant responses in BV-2 microglial cells. Neuromolecular Med. 2016;18(3):241–52. doi:10.1007/s12017-016-8411-0
   PubMed Web of Science ®Google Scholar
• Grogan PT, Sarkaria JN, Timmermann BN, Cohen MS. Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Invest New Drugs. 2014;32(4):604–17. doi:10.1007/s10637-014-0084-7
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Ranga RS, Burikhanov R, Han S-S, Chendil D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007;67(1):246–53. doi:10.1158/0008-5472.CAN-06-2430
   PubMed Web of Science ®Google Scholar
• Nishikawa Y, Okuzaki D, Fukushima K, Mukai S, Ohno S, Ozaki Y, Yabuta N, Nojima H. Withaferin A induces cell death selectively in androgen-independent prostate cancer cells but not in normal fibroblast cells. PLoS One. 2015;10(7):e0134137doi:10.1371/journal.pone.0134137
   PubMed Web of Science ®Google Scholar
• Rah B, Amin H, Yousuf K, Khan S, Jamwal G, Mukherjee D, Goswami A. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PloS One. 2012;7(9):e44039. doi:10.1371/journal.pone.0044039
   PubMed Web of Science ®Google Scholar
• Moselhy J, Suman S, Alghamdi M, Chandarasekharan B, Das TP, Houda A, Ankem M, Damodaran C. Withaferin A inhibits prostate carcinogenesis in a PTEN-deficient mouse model of prostate cancer. Neoplasia. 2017;19(6):451–9. doi:10.1016/j.neo.2017.04.005
   PubMed Web of Science ®Google Scholar
• Kim S-H, Singh KB, Hahm E-R, Lokeshwar BL, Singh SV. Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells. J Trad Complemen Med. 2020. doi:10.1016/j.jtcme.2020.02.002
   Google Scholar
• Muralikrishnan G, Dinda AK, Shakeel F. Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Invest. 2010;39(7):688–98. doi:10.3109/08820139.2010.487083
   PubMed Web of Science ®Google Scholar
• Koduru S, Kumar R, Srinivasan S, Evers MB, Damodaran C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther. 2010;9(1):202–10. doi:10.1158/1535-7163.MCT-09-0771
   PubMed Web of Science ®Google Scholar
• Das T, Roy KS, Chakrabarti T, Mukhopadhyay S, Roychoudhury S. Withaferin A modulates the Spindle Assembly Checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines. Biochem Pharmacol. 2014;91(1):31–9. doi:10.1016/j.bcp.2014.06.022
   PubMed Web of Science ®Google Scholar
• Choi BY, Kim B-W. Withaferin-A inhibits colon cancer cell growth by blocking STAT3 transcriptional activity. J Cancer Prev. 2015;20(3):185–92. doi:10.15430/JCP.2015.20.3.185
   PubMedGoogle Scholar
• Chandrasekaran B, Pal D, Kolluru V, Tyagi A, Baby B, Dahiya NR, Youssef K, Alatassi H, Ankem MK, Sharma AK, et al. The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models. Carcinogenesis. 2018;39(12):1537–47. doi:10.1093/carcin/bgy109
   PubMed Web of Science ®Google Scholar
• Alnuqaydan AM, Rah B, Almutary AG, Chauhan SS. Synergistic antitumor effect of 5-fluorouracil and withaferin-A induces endoplasmic reticulum stress-mediated autophagy and apoptosis in colorectal cancer cells. Am J Cancer Res. 2020;10(3):799–815.
   PubMed Web of Science ®Google Scholar
• Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS, Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis. 2008;13(12):1450–64. doi:10.1007/s10495-008-0271-0
   PubMed Web of Science ®Google Scholar
• Oza VP, Parmar PP, Kumar S, Subramanian R. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Appl Biochem Biotechnol. 2010;160(6):1833–40. doi:10.1007/s12010-009-8667-z
   PubMed Web of Science ®Google Scholar
• Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol in Vitro. 2011;25(8):1803–10. doi:10.1016/j.tiv.2011.09.016
   PubMed Web of Science ®Google Scholar
• Okamoto S, Tsujioka T, Suemori S-I, Kida J-I, Kondo T, Tohyama Y, Tohyama K. Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression. Cancer Sci. 2016;107(9):1302–14. doi:10.1111/cas.12988
   PubMed Web of Science ®Google Scholar
• Oh JH, Lee T-J, Kim SH, Choi YH, Lee SH, Lee JM, Kim Y-H, Park J-W, Kwon TK. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis. 2008;13(12):1494–504. doi:10.1007/s10495-008-0273-y
   PubMed Web of Science ®Google Scholar
• McKenna MK, Gachuki BW, Alhakeem SS, Oben KN, Rangnekar VM, Gupta RC, Bondada S. Anti-cancer activity of withaferin A in B-cell lymphoma. Cancer Biol Ther. 2015;16(7):1088–98. doi:10.1080/15384047.2015.1046651
   PubMed Web of Science ®Google Scholar
• Turrini E, Calcabrini C, Sestili P, Catanzaro E, de Gianni E, Diaz A, Hrelia P, Tacchini M, Guerrini A, Canonico B, et al. Withania somnifera induces cytotoxic and cytostatic effects on human T leukemia cells. Toxins. 2016;8(5):147. doi:10.3390/toxins8050147
   PubMed Web of Science ®Google Scholar
• Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, Larue L, Debuire B, Lemoine A, Brenner C, Lemaire C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis. 2011;16(10):1014–27. doi:10.1007/s10495-011-0625-x
   PubMed Web of Science ®Google Scholar
• Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med. 2005;2(1):99–105. doi:10.1093/ecam/neh064
   PubMed Web of Science ®Google Scholar
• Davis L, Kuttan G. Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol. 2001;75(2-3):165–8. doi:10.1016/s0378-8741(00)00404-9
   PubMed Web of Science ®Google Scholar
• Prakash J, Gupta SK, Dinda AK. Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Nutr Cancer. 2002;42(1):91–7. doi:10.1207/S15327914NC421_12
   PubMed Web of Science ®Google Scholar
• Lv TZ, Wang GS. Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2/M checkpoint proteins. Exp Ther Med. 2015;10(1):323–9. doi:10.3892/etm.2015.2480
   PubMed Web of Science ®Google Scholar
• Chang H-W, Li R-N, Wang H-R, Liu J-R, Tang J-Y, Huang H-W, Chan Y-H, Yen C-Y. Withaferin A induces oxidative stress-mediated apoptosis and DNA damage in oral cancer cells. Front Physiol. 2017;8:634doi:10.3389/fphys.2017.00634
   PubMed Web of Science ®Google Scholar
• Kim G, Kim T-H, Hwang E-H, Chang K-T, Hong JJ, Park J-H. Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis. Oncol Lett. 2017;14(1):416–22. doi:10.3892/ol.2017.6169
   PubMed Web of Science ®Google Scholar
• Li X, Zhu F, Jiang J, Sun C, Wang X, Shen M, Tian R, Shi C, Xu M, Peng F, et al. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Lett. 2015;357(1):219–30. doi:10.1016/j.canlet.2014.11.026
   PubMed Web of Science ®Google Scholar
• Fong MY, Jin S, Rane M, Singh RK, Gupta R, Kakar SS. Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PloS One. 2012;7(7):e42265. doi:10.1371/journal.pone.0042265
   PubMed Web of Science ®Google Scholar
• Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PloS One. 2014;9(9):e107596. doi:10.1371/journal.pone.0107596
   PubMed Web of Science ®Google Scholar
• Zhang X, Samadi AK, Roby KF, Timmermann B, Cohen MS. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol Oncol. 2012;124(3):606–12. doi:10.1016/j.ygyno.2011.11.044
   PubMed Web of Science ®Google Scholar
• Munagala R, Kausar H, Munjal C, Gupta RC. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis. 2011;32(11):1697–705. doi:10.1093/carcin/bgr192
   PubMed Web of Science ®Google Scholar
• Lee DH, Lim I-H, Sung E-G, Kim J-Y, Song I-H, Park YK, Lee T-J. Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway. Oncol Rep. 2013;30(2):933–8. doi:10.3892/or.2013.2487
   PubMed Web of Science ®Google Scholar
• Choi MJ, Park EJ, Min KJ, Park J-W, Kwon TK. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol in Vitro. 2011;25(3):692–8. doi:10.1016/j.tiv.2011.01.010
   PubMed Web of Science ®Google Scholar
• Um HJ, Min K-j, Kim DE, Kwon TK. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells. Biochem Biophys Res Commun. 2012;427(1):24–9. doi:10.1016/j.bbrc.2012.08.133
   PubMed Web of Science ®Google Scholar
• Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact. 2011;190(1):9–15. doi:10.1016/j.cbi.2011.01.015
   PubMed Web of Science ®Google Scholar
• Heyninck K, Lahtela-Kakkonen M, Van der Veken P, Haegeman G, Berghe WV. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ. Biochem Pharmacol. 2014;91(4):501–9. doi:10.1016/j.bcp.2014.08.004
   PubMed Web of Science ®Google Scholar
• Szarc Vel Szic K, Op de Beeck K, Ratman D, Wouters A, Beck IM, Declerck K, Heyninck K, Fransen E, Bracke M, De Bosscher K, et al. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PloS One. 2014;9(2):e87850. doi:10.1371/journal.pone.0087850
   PubMed Web of Science ®Google Scholar
• Zhang X, Mukerji R, Samadi AK, Cohen MS. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement Altern Med. 2011;11:84. doi:10.1186/1472-6882-11-84
   PubMed Web of Science ®Google Scholar
• Widodo N, Priyandoko D, Shah N, Wadhwa R, Kaul SC. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling. PLoS One. 2010;5(10):e13536. doi:10.1371/journal.pone.0013536
   PubMed Web of Science ®Google Scholar
• Chang E, Pohling C, Natarajan A, Witney TH, Kaur J, Xu L, Gowrishankar G, L D’Souza A, Murty S, Schick S, et al. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models. J Neurooncol. 2016;126(2):253–64. doi:10.1007/s11060-015-1972-1
   PubMed Web of Science ®Google Scholar
• Ting L-L, Chou A-B, Hsieh C-H, Hsiung S-C, Pang S-T, Liao S-K. Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1 carcinoma cell model. J Cancer Metastasis Treat. 2015;0(0):0–40. doi:10.4103/2394-4722.172008
   Google Scholar
• Cohen SM, Mukerji R, Timmermann BN, Samadi AK, Cohen MS. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Am J Surg. 2012;204(6):895–901. doi:10.1016/j.amjsurg.2012.07.027
   PubMed Web of Science ®Google Scholar
• Sharada AC, Solomon FE, Devi PU, Udupa N, Srinivasan KK. Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol. 1996;35(1):95–100. doi:10.3109/02841869609098486
   PubMed Web of Science ®Google Scholar
• Shohat B, Gitter S, Lavie D. Effect of withaferin A on Ehrlich ascites tumor cells-cytological observations. Int J Cancer. 1970;5(2):244–52. doi:10.1002/ijc.2910050212
   PubMed Web of Science ®Google Scholar
• Hahm E-R, Lee J, Kim S-H, Sehrawat A, Arlotti JA, Shiva SS, Bhargava R, Singh SV. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. J Natl Cancer Inst. 2013;105(15):1111–22. doi:10.1093/jnci/djt153
   PubMedGoogle Scholar
• Khazal KF, Hill DL, Grubbs CJ. Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice. Anticancer Res. 2014;34(11):6327–32.
   PubMed Web of Science ®Google Scholar
• Panjamurthy K, Manoharan S, Nirmal MR, Vellaichamy L. Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis. Invest New Drugs. 2009;27(5):447–52. doi:10.1007/s10637-008-9199-z
   PubMed Web of Science ®Google Scholar
• Leyon P, Kuttan G. Effect of Withania somnifera on B16F‐10 melanoma induced metastasis in mice. Phytother Res. 2004;18(2):118–22. doi:10.1002/ptr.1378
   PubMed Web of Science ®Google Scholar
• Yang H, Wang Y, Cheryan VT, Wu W, Cui CQ, Polin LA, Pass HI, Dou QP, Rishi AK, Wali A. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. PloS One. 2012;7(8):e41214. doi:10.1371/journal.pone.0041214
   PubMed Web of Science ®Google Scholar
• Usha P, Naidu M, Raju Y. Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infection. Drugs in R & D. 2003;4:103–9.
   Google Scholar
• Mikolai J, Erlandsen A, Murison A, Brown KA, Gregory WL, Raman-Caplan P, Zwickey HL. In vivo effects of ashwagandha (Withania somnifera) extract on the activation of lymphocytes. J Altern Complement Med. 2009;15(4):423–30. doi:10.1089/acm.2008.0215
   PubMed Web of Science ®Google Scholar
• Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther. 2013;12(4):312–22. doi:10.1177/1534735412464551
   PubMed Web of Science ®Google Scholar
• Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255. doi:10.4103/0253-7176.106022
   PubMedGoogle Scholar
• Bhat J, Damle A, Vaishnav PP, Albers R, Joshi M, Banerjee G. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother Res. 2010;24(1):129–35. doi:10.1002/ptr.2889
   PubMed Web of Science ®Google Scholar
• Chengappa KR, Brar JS, Gannon JM, Schlicht PJ. Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2018;79(5):0. doi:10.4088/JCP.17m11826
   Web of Science ®Google Scholar
• Srivastava A, Saxena A, Dixit S, Aggarwal S, Seenu V, Prashad R, Bhushan SM, Tranikanti V, Misra MC. An ayurvedic herbal compound to reduce toxicity to cancer chemotherapy: a randomized controlled trial. Indian J Med Paediatr Oncol. 2008;29(2):11. doi:10.4103/0971-5851.51426
   Google Scholar
• Vyas P, Thakar A, Baghel M, Sisodia A, Deole Y. Efficacy of Rasayana Avaleha as adjuvant to radiotherapy and chemotherapy in reducing adverse effects. Ayu. 2010;31(4):417–23. doi:10.4103/0974-8520.82029
   PubMedGoogle Scholar